Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adenovir Pharma AB

Anti-infectives for ophthalmic indications

This article was originally published in Start Up

Executive Summary

Epidemic keratoconjunctivitis is a viral eye infection caused by a number of different adenoviruses. The highly contagious disease causes inflammation of the cornea and conjunctiva, leading to irritation, itching, discharge and pain in the eye, swelling of the eyelids, photophobia, and blurred vision. These vision problems can last for months or even years in infected individuals. Adenovir Pharma AB aims to improve treatment of EKC with a “molecular wipe” that captures the virus and prevents it from binding to the surface of the eye.

Topics

Related Companies

UsernamePublicRestriction

Register

SC092235

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel